Market open
Seelos Therapeutics/SEEL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Seelos Therapeutics
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
Ticker
SEEL
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
8
Website
SEEL Metrics
BasicAdvanced
$1.3M
Market cap
0.06
P/E ratio
$47.06
EPS
1.86
Beta
-
Dividend rate
Price and volume
Market cap
$1.3M
Beta
1.86
52-week high
$3.71
52-week low
$2.77
Financial strength
Current ratio
0.076
Quick ratio
0.016
Total debt to equity
-36.104
Interest coverage (TTM)
-278.58%
Management effectiveness
Return on assets (TTM)
-261.11%
Return on equity (TTM)
-10.86%
Valuation
Price to earnings (TTM)
0.062
Price to revenue (TTM)
0.126
Price to book
-0.02
Price to tangible book (TTM)
-0.02
Price to free cash flow (TTM)
-0.019
Growth
Revenue change (TTM)
76.05%
Earnings per share change (TTM)
-101.73%
3-year earnings per share growth (CAGR)
-72.62%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Seelos Therapeutics stock?
Seelos Therapeutics (SEEL) has a market cap of $1.3M as of October 10, 2024.
What is the P/E ratio for Seelos Therapeutics stock?
The price to earnings (P/E) ratio for Seelos Therapeutics (SEEL) stock is 0.06 as of October 10, 2024.
Does Seelos Therapeutics stock pay dividends?
No, Seelos Therapeutics (SEEL) stock does not pay dividends to its shareholders as of October 10, 2024.
When is the next Seelos Therapeutics dividend payment date?
Seelos Therapeutics (SEEL) stock does not pay dividends to its shareholders.
What is the beta indicator for Seelos Therapeutics?
Seelos Therapeutics (SEEL) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.